Contact
Please use this form to send email to PR contact of this press release:
Karyopharm Announces Publication of XPOVIO™ (Selinexor) Phase 2b STORM Study Results in The New England Journal of Medicine
TO:
Please use this form to send email to PR contact of this press release:
Karyopharm Announces Publication of XPOVIO™ (Selinexor) Phase 2b STORM Study Results in The New England Journal of Medicine
TO: